Litcius/Paper detail

COVID-19 Case Fatality and Alzheimer’s Disease

Qiang Zhang, Jordan L. Schultz, Georgina M. Aldridge, Jacob E. Simmering, Youngcho Kim, Amy C. Ogilvie, Nandakumar S. Narayanan

2021Journal of Alzheimer s Disease27 citationsDOIOpen Access PDF

Abstract

Previous studies have identified dementia as a risk factor for death from coronavirus disease 2019 (COVID-19). However, it is unclear whether Alzheimer's disease (AD) is an independent risk factor for COVID-19 case fatality rate. In a retrospective cohort study, we identified 387,841 COVID-19 patients through TriNetX. After adjusting for demographics and comorbidities, we found that AD patients had higher odds of dying from COVID-19 compared to patients without AD (Odds Ratio: 1.20, 95%confidence interval: 1.09-1.32, p < 0.001). Interestingly, we did not observe increased mortality from COVID-19 among patients with vascular dementia. These data are relevant to the evolving COVID-19 pandemic.

Topics & Concepts

MedicineDiseaseCase fatality rateDemographicsRisk factorOddsRetrospective cohort studyCohortOdds ratioDementiaCohort studyAtherosclerotic cardiovascular diseasePediatricsCoronavirus disease 2019 (COVID-19)Multisystem diseaseInternal medicineEpidemiologyProtective factorCause of deathMEDLINELong-Term Effects of COVID-19Dementia and Cognitive Impairment ResearchIntensive Care Unit Cognitive Disorders
COVID-19 Case Fatality and Alzheimer’s Disease | Litcius